Sero survey shows 21.5% of those tested developed immunity against Covid-19

A total of 21.5% of those who were tested as part of a serological survey in Chennai were found to have developed immunity against coronavirus, the Greater Chennai Corporation (GCC) said

Coronavirus
Photo: Shutterstock
ANI General News
2 min read Last Updated : Sep 02 2020 | 7:54 AM IST

A total of 21.5 per cent of those who were tested as part of a serological survey in Chennai were found to have developed immunity against coronavirus, the Greater Chennai Corporation (GCC) said.

Samples of upwards of 12,000 people, who were selected at random, had been collected in July and tested as part of the test, which showed 21.5 per cent of people have developed immunity, GCC Commissioner Prakash said at a press conference here on Tuesday.

The GCC Commissioner, however, urged people to follow the guidelines and SOPs for the disease, at least for the coming three months even after relaxations came into force, and to continue wearing face masks and avoid unnecessary travelling.

He also said that with relaxations being announced contact tracing would become more difficult, therefore, family members of the symptomatic patients and office premises, in case an employee tests positive, will have to be canceled.

Prakash said that the COVID-19 positivity rate has reduced from 30 to nine per 100 persons.

As per the Union Health Ministry on Tuesday, Tamil Nadu had 52,578 active coronavirus cases, while 3,68,141 persons have been cured and discharged in the state. The state has also reported a high 7,322 number of deaths due to the infection.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsDelhi

First Published: Sep 02 2020 | 7:50 AM IST

Next Story